Marshall Wace, LLP Tenaya Therapeutics, Inc. Call Options Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$22.4 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$16.6 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$16 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$9.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$7.65 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $98.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...